$0.070
(0%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 12 November 2026 at 9:04am | ||||
RHINOMED LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (12-Nov) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
Rhinomed Ltd Constitution updated as approved at 2022 AGM
RNO released this announcement to the ASX on 21 November 2022, 9:21. The announcement is not marked as price sensitive, and is 48 page(s) in length and 312.09kb in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| Rhinomed Ltd Constitution updated as approved at 2022 AGM | 21 November 2022, 9:21 |
| Results of Meeting 2022 AGM | 18 November 2022, 15:55 |
| CEO presentation to 2022 AGM | 18 November 2022, 8:46 |
| Chairman's Address to Shareholders 2022 AGM | 18 November 2022, 8:45 |
If you were already registered, log in here.
If you were already registered, log in here.